Nifty Pharma index rises; Lupin, Cipla shares shine

NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday.

Shares of Lupin (up 1.64 per cent), Cipla (up 1.24 per cent), Piramal Enterprises (up 1.03 per cent) and Cadila Healthcare (up 0.90 per cent) were among the top gainers in the index.

Biocon (down 1.67 per cent), Aurobindo Pharma (down 0.63 per cent), Glenmark Pharmaceuticals (down 0.63 per cent) and Sun Pharmaceutical Industries (down 0.14 per cent) were trading in the red.

Benchmark NSE Nifty50 index was down 9.40 points at 10,575.8 while BSE Sensex was down 79.56 points at 35,078.99 at that time.

Among the 50 stocks in the Nifty index, 21 were trading in the green, while 29 were in the red.

Shares of YES Bank, SBI, Tata Motors, Ashok Leyland, Titan Company, Bank of Baroda, ICICI Bank, Vedanta, HPCL and Cipla were among the most traded shares on the National Stock Exchange.

  • Related Posts

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

    The Central Drugs Standard Control Organisation (CDSCO) found one spurious and 220 not of standard quality (NSQ) drug samples from a batch tested randomly as part of the August drug…

    FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

    The action follows the department’s investigation into a large-scale unlicenced drug repacking and relabelling racket uncovered at a farmhouse in Bengaluru South district’s Bidadi on August 18. The Karnataka Food…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

    FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

    FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman